A £7.5 million global challenge prize has launched to incentivise AI-based approaches to transform drug discovery for the treatment of amyotrophic lateral sclerosis (ALS).
ALS is a form of motor neurone disease (MND) that damages the…
MobiHealthNews’ Emerging Technologies Series will spotlight organizations developing, scaling and investing in innovative healthcare technologies. What follows is part one of an eight-part series:Precision Neuroscience is developing a brain-computer interface (BCI) to help patients…
Continue Reading
Breakthrough for ALS Patient
Elon Musk’s neurotechnology company Neuralink has achieved a remarkable milestone by successfully implanting its brain-computer interface (BCI) in Brad Smith, a man with ALS who is completely non-verbal. This groundbreaking implementation…
